AbergJA, GallantJE, AndersonJ, Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis2004;39:609–29
2.
ClumeckN, PozniakA, RaffiF, European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults. HIV Med2008;9:65–71
3.
SokP, HarwellJI, McGarveyST, Demographic and clinical characteristics of HIV-infected inpatients and outpatients at a Cambodian hospital. AIDS Patient Care STDS2006;20:369–78
4.
GhateM, DeshpandeS, TripathyS, Incidence of common opportunistic infections in HIV-infected individuals in Pune, India: analysis by stages of immunosuppression represented by CD4 counts. Int J Infect Dis2009;13:e1–8
5.
KitkungvanD, ApisarnthanarakA, LaowansiriP, MundyLM. Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense. HIV Med2008;9:636–41
6.
ChetchotisakdP, SungkanuparphS, ThinkhamropB, MootsikapunP, BoonyaprawitP. A multicentre, randomized, double-blind, placebo-controlled trial of primary cryptococcal meningitis prophylaxis in HIV-infected patients with severe immune deficiency. HIV Med2004;5:140–3
7.
Thailand Ministry of Public Health. Annual report 2004–2006. http://203.157.15.4/Annual/Total_Annual.html, January2007 (last accessed 1 May 2009)
8.
KhawcharoenpornT, ApisarnthanarakA, MundyLM. Assessment of risk for pulmonary tuberculosis after non-reactive tuberculin skin testing among patients with HIV infection in a resource-limited setting. Int J STD AIDS2008;19:843–7
9.
JarvisJN, LawnSD, VogtM, BanganiN, WoodR, HarrisonTS. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis2009;48:856–62
10.
KhawcharoenpornT, ApisarnthanarakA, MundyLM. Treatment of cryptococcosis in the setting of HIV coinfection. Expert Rev Anti Infect Ther2007;5:1019–30
